UTI- Pyelonephritis Management Flashcards

1
Q

What can pyelo develop to? (3)

A
  • Bacteremia
  • Sepsis
  • Acute renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

T/F can pyelo patients be managed as outpatient

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the resistance % tolerance for pyelo?

A

10% tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F urine culture is not indicated for all pyelo patients diagnosed

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the most common pathogen in pyelo?
What other bugs to expect (2)

A

E. coli still most common

Enterococcus
Pseudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When would it be reasonable to cover Enterococcus and pseudomonas in pyelo? (3)

A
  • If grown in recent culture in the last 3-6 months
  • if recent broad-spectrum antibiotic use
  • If ICU hospitalized
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What to give patients with pyelo if they are dehydrated?

A

IV fluids
- improve malaise, N/V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

For outpatient pyelo, which oral FQ has the most evidence? (2)

A

Levofloxacin and cipro (preferred)
- Resistance often over 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which FQ is not used in pyelo?

A

Moxifloxacin
- does not penetrate bladder enough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is usually given for empiric management in outpatients for pyelo? (2 options)

A

Long acting cephalosporin (ceftriaxone daily) until culture available

Can also give aminoglycoside (gentamicin) once daily
- tobramycin reserved for pseudo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which class and route of antibiotics have less evidence in outpatient pyelo

A

Oral beta-lactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the first line treatment for inpatient pyelo

A

IV 3rd gen cephalosporin (ceftriaxone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When would you use Pip-taz in inpatient pyelo?

A

If suspecting pseudomonas
- (ICU admission, recent culture)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When would you use carbapenem in inpatient pyelo

A

If concerned for ESBL
- Recent urine culture (<3 months) positive for ESBL
- Travel to Africa, Asia in the last 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What would you use in inpatient pyelo management if they have a type 4 beta lactam allergy?

A

IV Aminoglycosides
- only use when theres no other options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When can you use septra for inpatient pyelo?

A

For targeted therapy if susceptible (using antibiogram + culture results)

17
Q

When are tetracylcines used in inpatient pyelo?

A

USed for multi drug resistant organisms cystitis

18
Q

Which drugs are NOT used in pyelo? (2)

A

Nitrofurantoin
Fosfomycin
- inadequate concentrations in the kidney

19
Q

What do you do once culture results are available for pyelo

A

It is MONObacterial
- appropriate to target therapy

Can use urine culture to predict blood culture (if bacteremia is suspected)

20
Q

If a patient is not growing pseudomonas which carbapenem would you pick?

21
Q

Which generation do lab susceptibility test for cephalosporins? What can you infer from this results?

A

Test 1st gen parenteral -> Cefazolin
- can infer PARENTERAL susceptibility for 2nd and 3rd gen (Cefuroxime, cefotaxime, ceftriaxone)

22
Q

T/F Cefazolin susceptibility can be inferred for Cephalexin in UTI

23
Q

When is cephalexin susceptibility tested?

A

Only tested for cystitis

24
Q

T/F if the bug is resistant to cefazolin (1st gen IV) it will be resistant to 3rd gen IV cephalosporin

A

False
- Will go on to test 3rd gen

25
Q

What can we infer from cephalexin suscpetibility

A

Infers gram-neg susceptibility to cefprozil and cefuroxime (2nd gens)

  • DOES NOT INFER SUSCEPTIBILITY TO CEFADROXIL (1st gen)
26
Q

T/F labs will choose not to report data on broad spectrum agents if narrower options are available

27
Q

What does pan-susceptibile mean

A

Susceptible to all agents tested by the lab

28
Q

What does Pan-susceptible PsA mean?

A

susceptible to piperacillin (and pip-taz), ceftazidime, cipro/levofloxacin and imi/meropenem

29
Q

When should you convert IV to PO (2) Which class of drugs

A
  • tolerating oral intake (and no concerns of gut hypoperfusion) AND
  • Afebrile + showing improvement for 24 hours

Can usually convert around day 3 (earlier if fever resolves faster)

Class: Beta-lactams

30
Q

What if pyelo patient has bacteremia, would you extend IV duration?

A

If they have bacteremia, its less likely to cause seeding/serious infection (gram neg not as sticky)
- (no need for that 72 hour minimum with GAS bacteremia, for example)

Can just convert to HIGH dose oral beta lactam once criteria is met (tolerating PO and afebrile/improving for 24 hours)

31
Q

Define high dose beta lactams

A

Cephalexin 1g TID
Amoxicillin 1g TID

32
Q

What did the retrospective cohort study say for targeted enterobacterial Bacteremic UTI comparing high dose oral beta lactams and FQ or septra

A

As safe and effective as each other
- duration was 11 days

33
Q

What is the duration of therapy for the following classes:
FQ
Septra
BL

A

FQ: 5-7 days
- levo 5 days
- Cipro 7 days

Septra: 7 days
- can go for 10 days

BL: 7-10 days
- including IV therapy

34
Q

When would you see improvement in pyelo patients ?
Resolution?

A

Improvement: in 48-72 hours
Resolution: day 5

35
Q

What adjustments would you make to outpatients pyelo when cultures come back?

A

Will not narrow therapy
- however ensure that culture results show susceptibility

36
Q

What adjustments would you make to inpatients pyelo when cultures come back? (3)

A
  1. Narrow antibiotics
  2. Ensure adequate dosing as renal function improves
  3. Transition from IV BL to oral when feasible
37
Q

What can you infer from this urine culture showing for a CYSTITIS patient
Cefazolin (for systemic infection): resistant
Cephalexin (for cystitis): Susceptible

A

Can use either agent

Cefazolin only resistant for systemic infections

you can use Cefazolin IV or Cephalexin PO

38
Q

What can you infer from this urine culture showing for a PYELO patient
Cefazolin (for systemic infection): resistant
Cephalexin (for cystitis): Susceptible

A

CANNOT use either agent, won’t reach MIC

  • need to test 2nd/3rd gen parental cephalosporin to confirm

Can consider cipro

39
Q

What can you infer from this urine culture for a CYSTITIS patient
Cefazolin (for systemic infections): Susceptible
Cephalexin (for cystitis): Susceptible

A

Lab would still report both

Encourage the use of PO cephalexin for cystitis